Please login to the form below
Aragon Pharma
This page shows the latest Aragon Pharma news and features for those working in and with pharma, biotech and healthcare.
J&J’s Erleada first US drug for non-metastatic prostate cancer
J&J acquired Erleada when it took over Aragon Pharma in 2013 in a deal valued at $1bn.
Latest news
-
J&J completes Aragon deal as Seragon is born
The deal secures a promising new prostate cancer therapy for the pharma major in the form of Aragon's ARN-509, a second generation androgen receptor signalling inhibitor which has reached ... Seragon spun out. The closure of the deal also sees the
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Senior Content Editor - Biotechnology
-
Salary TBC
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- FDA approves new self-injection administration for Xolair
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
- Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
Quick links
Infographics
